Abstract:RNA interference (RNAi) inhibits gene expression by specifically degrading target mRNAs. Since the discovery of double-stranded small interference RNA (siRNA) in gene silencing(1), RNAi has become a powerful research tool in gene function studies. Compared to genetic deletion, RNAi-mediated gene silencing possesses many advantages, such as the ease with which it is carried out and its suitability to most cell lines. Multiple studies have demonstrated the applications of RNAi technology in cancer research. In particular, the development of the DNA vectorbased technology to produce small hairpin RNA (shRNA) driven by the U6 or H1 promoter has made long term and inducible gene silencing possible(2,3). Its use in combination with genetically engineered viral vectors, such as lentivirus, facilitates high efficiencies of shRNA delivery and/or integration into genomic DNA for stable shRNA expression.We describe a detailed procedure using the DNA vector-based RNAi technology to determine gene function, including construction of lentiviral vectors expressing shRNA, lentivirus production and cell infection, and functional studies using a mouse xenograft model.Various strategies have been reported in generating shRNA constructs. The protocol described here employing PCR amplification and a 3-fragment ligation can be used to directly and efficiently generate shRNA-containing lentiviral constructs without leaving any extra nucleotide adjacent to a shRNA coding sequence. Since the shRNA-expression cassettes created by this strategy can be cut out by restriction enzymes, they can be easily moved to other vectors with different fluorescent or antibiotic markers. Most commercial transfection reagents can be used in lentivirus production. However, in this report, we provide an economic method using calcium phosphate precipitation that can achieve over 90% transfection efficiency in 293T cells. Compared to constitutive shRNA expression vectors, an inducible shRNA system is particularly suitable to knocking down a gene essential to cell proliferation. We demonstrate the gene silencing of Yin Yang 1 (YY1), a potential oncogene in breast cancer(4,5), by a Tet-On inducible shRNA system and its effects on tumor formation. Research using lentivirus requires review and approval of a biosafety protocol by the Biosafety Committee of a researcher's institution. Research using animal models requires review and approval of an animal protocol by the Animal Care and Use Committee (ACUC) of a researcher's institution.

Study of Non-Viral Gene Transfer of NB4 Cells

The Non-Specific Binding Of Fluorescent-Labeled Mirnas On Cell Surface By Hydrophobic Interaction

Research Progress of Gene Silencing by RNA Interfering Technology in Mammal

Transferrin-Dressed Virus-like Ternary Nanoparticles with Aggregation-Induced Emission for Targeted Delivery and Rapid Cytosolic Release of siRNA.

Research Progress on Sirna Delivery with Nonviral Carriers

DNA Vector-Based RNA Interference to Study Gene Function in Cancer.

Comparison of Transfection Characters of Three Fluorescently Labeled Sirna in Vitro

Enhancing Gene Delivery in NB-4 Cells: Overcoming Transduction and Selection Challenges

Optimizing siRNA transfection by nanoparticle cationic polymer

Research progress on siRNA delivery with nonviral carriers.

A novel siRNA validation system for functional screening of effective RNAi targets in mammalian cells and development of a derivative lentivirus delivery system

Nonviral Methods for siRNA Delivery

Powering up the molecular therapy of RNA interference by novel nanoparticles (vol 4, pg 1051, 2016)

Isolation and Identification of Post-Transcriptional Gene Silencing-Related Micro-RNAs by Functionalized Silicon Nanowire Field-effect Transistor

Research Status and Prospect of Non-Viral Vectors Based on siRNA: A Review

Cationic Fluorescent Gold Nanoclusters for Nonviral siRNA Delivery

Progresses of non-viral targeted vectors in targeted delivery of siRNA

A Novel in Vitro Transcription Method for Producing Sirnas Without Specific Sequence Requirements

Efficient Self‐Assembled DNA Nanoparticles Through Rolling Circle Amplification for Sirna Delivery in Vitro

New insights into the mechanism of electrotransfer of small nucleic acids

Current status of non-viral siRNA vectors for therapy of cancers